# Exploring the Molecular Mechanism Based on KIT Mutation

> **NCT05895942** · — · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 190 (estimated)

## Conditions studied

- GIST

## Interventions

- **DRUG:** Imatinib

## Key facts

- **NCT ID:** NCT05895942
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-10
- **Primary completion:** 2024-09-10
- **Final completion:** 2025-09-10
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2023-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05895942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05895942, "Exploring the Molecular Mechanism Based on KIT Mutation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05895942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*